552 related articles for article (PubMed ID: 31130512)
1. OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome.
Xu R; Brawner AT; Li S; Liu JJ; Kim H; Xue H; Pang ZP; Kim WY; Hart RP; Liu Y; Jiang P
Cell Stem Cell; 2019 Jun; 24(6):908-926.e8. PubMed ID: 31130512
[TBL] [Abstract][Full Text] [Related]
2. Generation of improved human cerebral organoids from single copy DYRK1A knockout induced pluripotent stem cells in trisomy 21: hypothetical solutions for neurodevelopmental models and therapeutic alternatives in down syndrome.
Çağlayan ES
Cell Biol Int; 2016 Dec; 40(12):1256-1270. PubMed ID: 27743462
[TBL] [Abstract][Full Text] [Related]
3. Olig2 defines a subset of neural stem cells that produce specific olfactory bulb interneuron subtypes in the subventricular zone of adult mice.
Del Águila Á; Adam M; Ullom K; Shaw N; Qin S; Ehrman J; Nardini D; Salomone J; Gebelein B; Lu QR; Potter SS; Waclaw R; Campbell K; Nakafuku M
Development; 2022 Mar; 149(5):. PubMed ID: 35132995
[TBL] [Abstract][Full Text] [Related]
4. Olig2 regulates Purkinje cell generation in the early developing mouse cerebellum.
Ju J; Liu Q; Zhang Y; Liu Y; Jiang M; Zhang L; He X; Peng C; Zheng T; Lu QR; Li H
Sci Rep; 2016 Jul; 6():30711. PubMed ID: 27469598
[TBL] [Abstract][Full Text] [Related]
5. OLIG2 over-expression impairs proliferation of human Down syndrome neural progenitors.
Lu J; Lian G; Zhou H; Esposito G; Steardo L; Delli-Bovi LC; Hecht JL; Lu QR; Sheen V
Hum Mol Genet; 2012 May; 21(10):2330-40. PubMed ID: 22343408
[TBL] [Abstract][Full Text] [Related]
6. Pluripotent Stem Cell-Derived Cerebral Organoids Reveal Human Oligodendrogenesis with Dorsal and Ventral Origins.
Kim H; Xu R; Padmashri R; Dunaevsky A; Liu Y; Dreyfus CF; Jiang P
Stem Cell Reports; 2019 May; 12(5):890-905. PubMed ID: 31091434
[TBL] [Abstract][Full Text] [Related]
7. DSCAM/PAK1 pathway suppression reverses neurogenesis deficits in iPSC-derived cerebral organoids from patients with Down syndrome.
Tang XY; Xu L; Wang J; Hong Y; Wang Y; Zhu Q; Wang D; Zhang XY; Liu CY; Fang KH; Han X; Wang S; Wang X; Xu M; Bhattacharyya A; Guo X; Lin M; Liu Y
J Clin Invest; 2021 Jun; 131(12):. PubMed ID: 33945512
[TBL] [Abstract][Full Text] [Related]
8. Abnormal mitochondria in Down syndrome iPSC-derived GABAergic interneurons and organoids.
Xu L; Huo HQ; Lu KQ; Tang XY; Hong Y; Han X; Fu ZX; Fang KH; Xu M; Guo X; Liu Y
Biochim Biophys Acta Mol Basis Dis; 2022 Jun; 1868(6):166388. PubMed ID: 35301086
[TBL] [Abstract][Full Text] [Related]
9. Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical region.
Liu W; Zhou H; Liu L; Zhao C; Deng Y; Chen L; Wu L; Mandrycky N; McNabb CT; Peng Y; Fuchs PN; Lu J; Sheen V; Qiu M; Mao M; Lu QR
Neurobiol Dis; 2015 May; 77():106-16. PubMed ID: 25747816
[TBL] [Abstract][Full Text] [Related]
10. Prox1 regulates Olig2 expression to modulate binary fate decisions in spinal cord neurons.
Kaltezioti V; Antoniou D; Stergiopoulos A; Rozani I; Rohrer H; Politis PK
J Neurosci; 2014 Nov; 34(47):15816-31. PubMed ID: 25411508
[TBL] [Abstract][Full Text] [Related]
11. Neurogenesis impairment: An early developmental defect in Down syndrome.
Stagni F; Giacomini A; Emili M; Guidi S; Bartesaghi R
Free Radic Biol Med; 2018 Jan; 114():15-32. PubMed ID: 28756311
[TBL] [Abstract][Full Text] [Related]
12. Modeling Down Syndrome with Patient iPSCs Reveals Cellular and Migration Deficits of GABAergic Neurons.
Huo HQ; Qu ZY; Yuan F; Ma L; Yao L; Xu M; Hu Y; Ji J; Bhattacharyya A; Zhang SC; Liu Y
Stem Cell Reports; 2018 Apr; 10(4):1251-1266. PubMed ID: 29526735
[TBL] [Abstract][Full Text] [Related]
13. Dosage Counts: Correcting Trisomy-21-Related Phenotypes in Human Organoids and Xenografts.
Manley WF; Anderson SA
Cell Stem Cell; 2019 Jun; 24(6):835-836. PubMed ID: 31173710
[TBL] [Abstract][Full Text] [Related]
14. Generation of Urine-Derived Induced Pluripotent Stem Cells and Cerebral Organoids for Modeling Down Syndrome.
Teles E Silva AL; Yokota BY; Sertié AL; Zampieri BL
Stem Cell Rev Rep; 2023 May; 19(4):1116-1123. PubMed ID: 36652145
[TBL] [Abstract][Full Text] [Related]
15. Neurons Derived from Human Induced Pluripotent Stem Cells Integrate into Rat Brain Circuits and Maintain Both Excitatory and Inhibitory Synaptic Activities.
Yin X; Xu JC; Cho GS; Kwon C; Dawson TM; Dawson VL
eNeuro; 2019; 6(4):. PubMed ID: 31413152
[TBL] [Abstract][Full Text] [Related]
16. Age-Dependent Decline in Fate Switch from NG2 Cells to Astrocytes After Olig2 Deletion.
Zuo H; Wood WM; Sherafat A; Hill RA; Lu QR; Nishiyama A
J Neurosci; 2018 Feb; 38(9):2359-2371. PubMed ID: 29382710
[TBL] [Abstract][Full Text] [Related]
17. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain].
Kurabayashi N; Sanada K
Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289
[TBL] [Abstract][Full Text] [Related]
18. In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid.
Nam KH; Yi SA; Jang HJ; Han JW; Lee J
Arch Pharm Res; 2020 Sep; 43(9):877-889. PubMed ID: 32761309
[TBL] [Abstract][Full Text] [Related]
19. Generation of iPSC-derived Human Brain Organoids to Model Early Neurodevelopmental Disorders.
Gabriel E; Gopalakrishnan J
J Vis Exp; 2017 Apr; (122):. PubMed ID: 28448044
[TBL] [Abstract][Full Text] [Related]
20. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
Lee CT; Bendriem RM; Wu WW; Shen RF
J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
